A prognostic model based on adrenergic receptor signaling pathways and cell type characteristics stratifies patients according to risk, demonstrating the potential of ADRB1+ T cells as prognostic indicators of ESCC. The gene discussed is ADRB1; the disease is esophageal squamous cell carcinoma.